A mutant NT-3 selective for TrkC, and an agonistic mAb that activates TrkC (Guillemard et al., 2010) selectively protected motor neurons in an ALS model (Enomoto et al., 2013; Brahimi et al., 2016). This evidence concerns the gene NTRK3 and amyotrophic lateral sclerosis.